{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:52:29Z","timestamp":1792036349991,"version":"4.4.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2143920"],"award-info":[{"award-number":["2143920"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["F31NS137623"],"award-info":[{"award-number":["F31NS137623"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS122751"],"award-info":[{"award-number":["R01-NS122751"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS124784"],"award-info":[{"award-number":["R01NS124784"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS114413"],"award-info":[{"award-number":["R01-NS114413"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["U01-FD008126"],"award-info":[{"award-number":["U01-FD008126"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.nbd.2025.106827","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T11:08:03Z","timestamp":1738408083000},"page":"106827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Cerebellar lipid dysregulation in SCA3: A comparative study in patients and mice"],"prefix":"10.1016","volume":"206","author":[{"given":"Alexandra F.","family":"Putka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varshasnata","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Cologna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley S.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.106827_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1194\/jlr.P071639","article-title":"Defective cholesterol metabolism in amyotrophic lateral sclerosis","volume":"58","author":"Abdel-Khalik","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2025.106827_bb0010","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.nicl.2018.06.011","article-title":"Autosomal dominant cerebellar ataxias: imaging biomarkers with high effect sizes","volume":"19","author":"Adanyeguh","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.nbd.2025.106827_bb0015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12311-020-01137-3","article-title":"Volumetric MRI changes in spinocerebellar Ataxia (SCA3 and SCA10) patients","volume":"19","author":"Arruda","year":"2020","journal-title":"Cerebellum"},{"key":"10.1016\/j.nbd.2025.106827_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","article-title":"Altered cholesterol and fatty acid metabolism in Huntington disease","volume":"4","author":"Block","year":"2010","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.nbd.2025.106827_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2021.103670","article-title":"Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration","volume":"116","author":"Blomqvist","year":"2021","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2025.106827_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-4157(78)90006-0","article-title":"Structural organization of the human myelin membrane","volume":"515","author":"Boggs","year":"1978","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2025.106827_bb0035","series-title":"Molecular Biology of the Cell","first-page":"1463","author":"Bruce Alberts","year":"2002"},{"key":"10.1016\/j.nbd.2025.106827_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.conb.2021.07.001","article-title":"Polyglutamine diseases","volume":"72","author":"Bunting","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2025.106827_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12311-020-01179-7","article-title":"Antisense oligonucleotide therapy targeted against ATXN3 improves Potassium Channel-mediated Purkinje neuron dysfunction in spinocerebellar Ataxia type 3","volume":"20","author":"Bushart","year":"2020","journal-title":"Cerebellum"},{"key":"10.1016\/j.nbd.2025.106827_bb0050","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/mds.28109","article-title":"A critical review of white matter changes in Huntington\u2019s disease","volume":"35","author":"Casella","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106827_bb0055","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","article-title":"YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit","volume":"11","author":"Cemal","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.106827_bb0060","article-title":"Clinically meaningful MR endpoints sensitive to preataxic SCA1 and SCA3","author":"Chandrasekaran","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0065","doi-asserted-by":"crossref","first-page":"11642","DOI":"10.1038\/s41598-019-48059-7","article-title":"Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis","volume":"9","author":"Chaves-Filho","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.106827_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00598","article-title":"Involvement of lipids in Alzheimer\u2019s disease pathology and potential therapies","volume":"11","author":"Chew","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.nbd.2025.106827_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1194\/jlr.R009761","article-title":"Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models","volume":"52","author":"Chrast","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2025.106827_bb0080","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1021\/acs.chemrev.8b00451","article-title":"Emerging diversity in lipid-protein interactions","volume":"119","author":"Corradi","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.nbd.2025.106827_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28140","article-title":"In vivo molecular signatures of cerebellar pathology in spinocerebellar Ataxia type 3","volume":"35","author":"Costa","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106827_bb0090","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1529\/biophysj.104.048397","article-title":"Lipid-protein interactions of integral membrane proteins: a comparative simulation study","volume":"87","author":"Deol","year":"2004","journal-title":"Biophys. J."},{"key":"10.1016\/j.nbd.2025.106827_bb0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","article-title":"Autosomal dominant cerebellar ataxias: Polyglutamine expansions and beyond","volume":"9","author":"Durr","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0100","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.410390411","article-title":"Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features","volume":"39","author":"Durr","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0105","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/mds.28610","article-title":"Regional brain and spinal cord volume loss in spinocerebellar Ataxia type 3","volume":"36","author":"Faber","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106827_bb0110","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1194\/jlr.E400004-JLR200","article-title":"A comprehensive classification system for lipids","volume":"46","author":"Fahy","year":"2005","journal-title":"J. Lipid Res."},{"issue":"Suppl","key":"10.1016\/j.nbd.2025.106827_bb0115","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1194\/jlr.R800095-JLR200","article-title":"Update of the LIPID MAPS comprehensive classification system for lipids","volume":"50","author":"Fahy","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2025.106827_bb0120","first-page":"3","article-title":"Parkinson\u2019s disease: proteinopathy or lipidopathy? Npj","volume":"6","author":"Fanning","year":"2020","journal-title":"Parkinson\u2019s Disease."},{"key":"10.1016\/j.nbd.2025.106827_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105933","article-title":"Longitudinal spatial mapping of lipid metabolites reveals pre-symptomatic changes in the hippocampi of Huntington\u2019s disease transgenic mice","volume":"176","author":"Farzana","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106827_bb0130","article-title":"Cerebellar Volumetry in ataxias: relation to Ataxia severity and duration","author":"Ferreira","year":"2024","journal-title":"Cerebellum"},{"key":"10.1016\/j.nbd.2025.106827_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tins.2023.11.003","article-title":"White matter injury across neurodegenerative disease","volume":"47","author":"Festa","year":"2024","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2025.106827_bb0140","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.106827_bb0145","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaneurol.2019.0423","article-title":"Prevalence of carriers of intermediate and pathological Polyglutamine disease-associated alleles among large population-based cohorts","volume":"76","author":"Gardiner","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0150","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.25451","article-title":"A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3","volume":"28","author":"Guimaraes","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106827_bb0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm.2017.138","article-title":"Understanding the diversity of membrane lipid composition","volume":"19","author":"Harayama","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2025.106827_bb0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/jnc.14468","article-title":"Subventricular zone lipidomic architecture loss in Huntington\u2019s disease","volume":"146","author":"Hunter","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106827_bb0165","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1111\/jnc.15325","article-title":"An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington\u2019s disease caudate nucleus","volume":"157","author":"Hunter","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106827_bb0170","unstructured":"Hutch, F., interactiveVolcano. 2021."},{"key":"10.1016\/j.nbd.2025.106827_bb0175","series-title":"Intermolecular and Surface Forces (Third Edition)","first-page":"535","article-title":"20 - soft and biological structures","author":"Israelachvili","year":"2011"},{"key":"10.1016\/j.nbd.2025.106827_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci9120354","article-title":"Diffusion tensor magnetic resonance imaging for differentiating multiple system atrophy cerebellar type and spinocerebellar Ataxia type 3","volume":"9","author":"Jao","year":"2019","journal-title":"Brain Sci."},{"key":"10.1016\/j.nbd.2025.106827_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.797220","article-title":"Altered cholesterol homeostasis in Huntington\u2019s disease","volume":"14","author":"Kacher","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2025.106827_bb0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00415-013-7186-6","article-title":"White matter damage is related to ataxia severity in SCA3","volume":"261","author":"Kang","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041505","article-title":"Lipids and Alzheimer\u2019s disease","volume":"21","author":"Kao","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.106827_bb0200","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrneurol.2011.132","article-title":"Cholesterol metabolism in Huntington disease","volume":"7","author":"Karasinska","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0205","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/bs.mie.2017.06.004","article-title":"Syntheses of fluorescent gangliosides for the studies of raft domains","volume":"597","author":"Komura","year":"2017","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.nbd.2025.106827_bb0210","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.bbamem.2011.07.022","article-title":"Fluid phase lipid areas and bilayer thicknesses of commonly used phosphatidylcholines as a function of temperature","volume":"1808","author":"Kucerka","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2025.106827_bb0215","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1007\/s00415-021-10890-2","article-title":"Brain structural abnormalities in the preclinical stage of Machado-Joseph disease\/spinocerebellar ataxia type 3 (MJD\/SCA3): evaluation by MRI morphometry, diffusion tensor imaging and neurite orientation dispersion and density imaging","volume":"269","author":"Li","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0220","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1194\/jlr.M033506","article-title":"Shorthand notation for lipid structures derived from mass spectrometry","volume":"54","author":"Liebisch","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2025.106827_bb0225","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1194\/jlr.S120001025","article-title":"Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures","volume":"61","author":"Liebisch","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2025.106827_bb0230","article-title":"To close or to collapse: the role of charges on membrane stability upon pore formation","volume":"8","author":"Lira","year":"2021","journal-title":"Adv Sci (Weinh)."},{"key":"10.1016\/j.nbd.2025.106827_bb0235","doi-asserted-by":"crossref","first-page":"1197822","DOI":"10.3389\/fneur.2023.1197822","article-title":"Voxel-based meta-analysis of gray matter and white matter changes in patients with spinocerebellar ataxia type 3","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0240","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neulet.2006.09.007","article-title":"Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study","volume":"408","author":"Lukas","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2025.106827_bb0245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.25264","article-title":"Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice","volume":"84","author":"McLoughlin","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104635","article-title":"Pathogenesis of SCA3 and implications for other polyglutamine diseases","volume":"134","author":"McLoughlin","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106827_bb0255","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giz061","article-title":"LION\/web: a web-based ontology enrichment tool for lipidomic data analysis","volume":"8","author":"Molenaar","year":"2019","journal-title":"Gigascience"},{"key":"10.1016\/j.nbd.2025.106827_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.103042","article-title":"Lipidomic profiling of rat hepatic stellate cells during activation reveals a two-stage process accompanied by increased levels of lysosomal lipids","volume":"299","author":"Molenaar","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.106827_bb0265","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.semcdb.2020.07.016","article-title":"Lipids in regulating oligodendrocyte structure and function","volume":"112","author":"Montani","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.nbd.2025.106827_bb0270","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.omtn.2017.04.005","article-title":"Evaluation of antisense oligonucleotides targeting ATXN3 in SCA3 mouse models","volume":"7","author":"Moore","year":"2017","journal-title":"Mol Ther Nucleic Acids."},{"key":"10.1016\/j.nbd.2025.106827_bb0275","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41592-022-01710-0","article-title":"Guiding the choice of informatics software and tools for lipidomics research applications","volume":"20","author":"Ni","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2025.106827_bb0280","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1471-4159.1973.tb07520.x","article-title":"Myelination in rat brain: changes in myelin composition during brain maturation","volume":"21","author":"Norton","year":"1973","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106827_bb0285","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1126\/science.147.3662.1099","article-title":"Stability of the myelin membrane","volume":"147","author":"O\u2019Brien","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.106827_bb0290","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0022-2275(20)39619-X","article-title":"Lipid composition of the normal human brain: gray matter, white matter, and myelin","volume":"6","author":"O\u2019Brien","year":"1965","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2025.106827_bb0295","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaw2964","article-title":"LIPID MAPS: serving the next generation of lipid researchers with tools, resources, data, and training","volume":"12","author":"O\u2019Donnell","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.nbd.2025.106827_bb0300","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.mrgentox.2013.06.023","article-title":"Association between Machado-Joseph disease and oxidative stress biomarkers","volume":"757","author":"Pacheco","year":"2013","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.nbd.2025.106827_bb0305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/jnc.13738","article-title":"Novel molecular insights into the critical role of sulfatide in myelin maintenance\/function","volume":"139","author":"Palavicini","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106827_bb0310","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.bbamem.2012.05.007","article-title":"Molecular structures of fluid phase phosphatidylglycerol bilayers as determined by small angle neutron and X-ray scattering","volume":"1818","author":"Pan","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2025.106827_bb0315","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fneur.2020.00411","article-title":"Assessment of cerebral and cerebellar white matter microstructure in spinocerebellar ataxias 1, 2, 3, and 6 using diffusion MRI","volume":"11","author":"Park","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","article-title":"Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3","volume":"19","author":"Paulson","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106827_bb0325","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrn.2017.92","article-title":"Polyglutamine spinocerebellar ataxias - from genes to potential treatments","volume":"18","author":"Paulson","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2025.106827_bb0330","doi-asserted-by":"crossref","first-page":"fcab303","DOI":"10.1093\/braincomms\/fcab303","article-title":"The long and the short of Huntington\u2019s disease: how the sphingolipid profile is shifted in the caudate of advanced clinical cases","volume":"4","author":"Phillips","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.nbd.2025.106827_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040812","article-title":"Myelin fat facts: an overview of lipids and fatty acid metabolism","volume":"9","author":"Poitelon","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2025.106827_bb0340","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/cells12040601","article-title":"Myelinating glia: potential therapeutic targets in Polyglutamine spinocerebellar ataxias","volume":"12","author":"Putka","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2025.106827_bb0345","series-title":"Characteristic Composition of Myelin. Basic Neurochemistry\u202f: Molecular, Cellular and Medical Aspects","author":"Quarles","year":"1999"},{"key":"10.1016\/j.nbd.2025.106827_bb0350","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1093\/hmg\/ddx224","article-title":"Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes","volume":"26","author":"Ramani","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.106827_bib466","doi-asserted-by":"crossref","unstructured":"Ramani B, Harris GM, Huang R, Seki T, Murphy GG, Costa Mdo C, Fischer S, Saunders TL, Xia G, McEachin RC, Paulson HL. A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript. Hum Mol Genet. 2015 Mar 1;24(5):1211-24. doi: 10.1093\/hmg\/ddu532. Epub 2014 Oct 15. Erratum in: Hum Mol Genet. 2017 Aug 15;26(16):3232-3233. doi: 10.1093\/hmg\/ddx176. PMID: 25320121; PMCID: PMC4321438.","DOI":"10.1093\/hmg\/ddx176"},{"key":"10.1016\/j.nbd.2025.106827_bb0355","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s12192-012-0346-2","article-title":"Basal and stress-induced Hsp70 are modulated by ataxin-3","volume":"17","author":"Reina","year":"2012","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.nbd.2025.106827_bb0360","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ana.25297","article-title":"Structural signature of SCA3: from presymptomatic to late disease stages","volume":"84","author":"Rezende","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0365","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2013.01.001","article-title":"Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7","volume":"104","author":"Rub","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2025.106827_bb0370","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbrc.2007.08.062","article-title":"Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination","volume":"362","author":"Schmitt","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2025.106827_bb0375","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bbalip.2014.12.016","article-title":"Metabolism and functions of lipids in myelin","volume":"1851","author":"Schmitt","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2025.106827_bb0380","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroimage.2009.07.027","article-title":"Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6","volume":"49","author":"Schulz","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2025.106827_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162615","article-title":"Pathogenetic mechanisms underlying spinocerebellar Ataxia type 3 are altered in primary oligodendrocyte culture","volume":"11","author":"Schuster","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2025.106827_bb0390","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1954-20.2021","article-title":"Impaired oligodendrocyte maturation is an early feature in SCA3 disease pathogenesis","volume":"42","author":"Schuster","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106827_bb0395","doi-asserted-by":"crossref","first-page":"1118429","DOI":"10.3389\/fnins.2023.1118429","article-title":"Disease-associated oligodendrocyte signatures are spatiotemporally dysregulated in spinocerebellar ataxia type 3","volume":"17","author":"Schuster","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2025.106827_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2024.02.033","article-title":"ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice","author":"Schuster","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2025.106827_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yclnex.2018.05.001","article-title":"Lipids: an insight into the neurodegenerative disorders","volume":"20","author":"Shamim","year":"2018","journal-title":"Clin. Nutr. Exp."},{"key":"10.1016\/j.nbd.2025.106827_bb0410","doi-asserted-by":"crossref","first-page":"14911","DOI":"10.1038\/s41598-023-41192-4","article-title":"High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression","volume":"13","author":"Stahl","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.106827_bb0415","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2024.12.055","article-title":"White matter functional and structural alterations of spinocerebellar ataxia type 3: a longitudinal MRI study","volume":"567","author":"Tang","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.106827_bb0420","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-018-0261-9","article-title":"Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model","volume":"13","author":"Toonen","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.106827_bb0425","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41582-023-00864-5","article-title":"The translational potential of cholesterol-based therapies for neurological disease","volume":"19","author":"Valenza","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0430","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3389\/fnins.2020.00749","article-title":"MR imaging of SCA3\/MJD","volume":"14","author":"Wan","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2025.106827_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010131","article-title":"Lipids as emerging biomarkers in neurodegenerative diseases","volume":"25","author":"Wei","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.106827_bb0440","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3389\/fneur.2017.00714","article-title":"Microstructural alterations in asymptomatic and symptomatic patients with spinocerebellar Ataxia type 3: a tract-based spatial statistics study","volume":"8","author":"Wu","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2025.106827_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010027","article-title":"The role of lipids in Parkinson\u2019s disease","volume":"8","author":"Xicoy","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2025.106827_bb0450","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fnmol.2019.00159","article-title":"Metabolic profiling reveals biochemical pathways and potential biomarkers of spinocerebellar Ataxia 3","volume":"12","author":"Yang","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2025.106827_bb0455","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/metabo15010010","article-title":"Lipidomics of Huntington\u2019s disease: a comprehensive review of current status and future directions","volume":"15","author":"Yilmaz","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.nbd.2025.106827_bb0460","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/j.1471-4159.1991.tb06435.x","article-title":"Exogenous GM3 ganglioside stimulates process formation and glycoprotein release by cultured bovine oligodendrocytes","volume":"57","author":"Yim","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106827_bb0465","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jnr.490380305","article-title":"Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside","volume":"38","author":"Yim","year":"1994","journal-title":"J. Neurosci. Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:57:07Z","timestamp":1778576227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":94,"alternative-id":["S0969996125000439"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106827","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebellar lipid dysregulation in SCA3: A comparative study in patients and mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106827"}}